These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36828949)

  • 1. Enhanced Transdermal Delivery of N-Acetylcysteine and 4-Phenylbutyric Acid for Potential Use as Antidotes to Lewisite.
    Dandekar AA; Vora D; Yeh JS; Srivastava RK; Athar M; Banga AK
    AAPS PharmSciTech; 2023 Feb; 24(3):71. PubMed ID: 36828949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneedle-mediated transdermal delivery of N-acetyl cysteine as a potential antidote for lewisite injury.
    Kshirsagar S; Dandekar A; Srivastava RK; Khan J; Muzaffar S; Athar M; Banga AK
    Int J Pharm; 2023 Nov; 647():123547. PubMed ID: 37884214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of physical and chemical enhancement techniques for transdermal delivery of linagliptin.
    Karve T; Banga AK
    Int J Pharm; 2024 Apr; 654():123992. PubMed ID: 38479485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of vancomycin hydrochloride: Influence of chemical and physical permeation enhancers.
    Datta D; Panchal DS; Venuganti VVK
    Int J Pharm; 2021 Jun; 602():120663. PubMed ID: 33933644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanism Underlying Pathogenesis of Lewisite-Induced Cutaneous Blistering and Inflammation: Chemical Chaperones as Potential Novel Antidotes.
    Li C; Srivastava RK; Weng Z; Croutch CR; Agarwal A; Elmets CA; Afaq F; Athar M
    Am J Pathol; 2016 Oct; 186(10):2637-49. PubMed ID: 27528504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A; Vyas H; Shah J; Kumar A
    Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing topical delivery of ISRIB: Optimizing cream formulations with chemical enhancers and pH adjustment.
    Radmard A; Kumar Srivastava R; Shrestha N; Khan J; Muzaffar S; Athar M; Banga AK
    Int J Pharm; 2024 Nov; 665():124661. PubMed ID: 39244069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of iontophoresis and penetration enhancers on transdermal absorption of metopimazine.
    Bounoure F; Lahiani Skiba M; Besnard M; Arnaud P; Mallet E; Skiba M
    J Dermatol Sci; 2008 Dec; 52(3):170-7. PubMed ID: 18678472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride.
    Puri A; Murnane KS; Blough BE; Banga AK
    Int J Pharm; 2017 Aug; 528(1-2):452-462. PubMed ID: 28633107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis.
    Nair A; Reddy C; Jacob S
    Skin Res Technol; 2009 May; 15(2):187-94. PubMed ID: 19622129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.
    Meidan VM; Al-Khalili M; Michniak BB
    Int J Pharm; 2003 Oct; 264(1-2):73-83. PubMed ID: 12972337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of 4-phenylbutyric acid microsponge gel formulations for the treatment of lewisite-mediated skin injury.
    Kshirsagar SM; Viswaroopan N; Ghosh M; Junaid MSA; Haque S; Khan J; Muzaffar S; Srivastava RK; Athar M; Banga AK
    Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38802678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of matrix patches for transdermal delivery of a highly lipophilic antiestrogen.
    Funke AP; Günther C; Müller RH; Lipp R
    Drug Dev Ind Pharm; 2003 Aug; 29(7):785-93. PubMed ID: 12906336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Characterization of Atenolol Transdermal Therapeutic Systems: Enhancement of Permeability via Iontophoresis.
    Keerthi H; Panakanti PK; Yamsani MR
    PDA J Pharm Sci Technol; 2012; 66(4):318-32. PubMed ID: 22767881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.
    Nair AB; Vaka SR; Gupta S; Repka MA; Murthy SN
    Pharm Dev Technol; 2012; 17(2):158-63. PubMed ID: 20958130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
    Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
    Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of penetration enhancers on permeation kinetics of nitrendipine in two different skin models.
    Mittal A; Sara UV; Ali A; Aqil M
    Biol Pharm Bull; 2008 Sep; 31(9):1766-72. PubMed ID: 18758074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating transdermal delivery of vitamin D3.
    Alsaqr A; Rasoully M; Musteata FM
    AAPS PharmSciTech; 2015 Aug; 16(4):963-72. PubMed ID: 25609377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin Delivery and Irritation Potential of Phenmetrazine as a Candidate Transdermal Formulation for Repurposed Indications.
    Jiang Y; Murnane KS; Bhattaccharjee SA; Blough BE; Banga AK
    AAPS J; 2019 May; 21(4):70. PubMed ID: 31152318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.